Literature DB >> 12653815

Short-term outcomes after brief ambulatory opioid detoxification with buprenorphine in young heroin users.

Devang H Gandhi1, Jerome H Jaffe, Scot McNary, Greg J Kavanagh, Michael Hayes, Marian Currens.   

Abstract

AIMS: This study examines the outcomes at 1, 3 and 6 months after a very brief outpatient detoxification with buprenorphine in 18-25-year-old heroin users.
DESIGN: Prospective follow-up study.
SETTING: Outpatient drug treatment clinic, providing brief detoxification in downtown Baltimore, Maryland, USA. PARTICIPANTS: One hundred and twenty-three subjects between 18 and 25 years old; 56% male; 95% Caucasian; seeking detoxification; living in Baltimore City and five surrounding counties. INTERVENTION: Detoxification with buprenorphine over 3 days. Follow-up at 1, 3 and 6 months. MEASUREMENTS: Drug use history, the Addiction Severity Index at baseline and follow-up, urine drug screens, evaluation of the detoxification experience.
FINDINGS: By self-report, 37% of the total sample were not currently using heroin at 1 month, 32% at 3 months and 29% at 6 months, and 6.7%, 10.1% and 11.8% had an opioid negative urine test at 1, 3 and 6 months, respectively. There was a significant reduction from the baseline in mean Addiction Severity Index drug use composite score, as well as the mean number of days of heroin and cocaine use during past 30 days, that was sustained over the three follow-up points. Engagement in aftercare was generally poor.
CONCLUSIONS: The findings show a reduced frequency and intensity of drug use, suggesting a possible role for brief outpatient detoxification in reducing the severity of dependence for some younger heroin users who may not yet be ready to engage in long-term abstinence-oriented or opioid substitution treatments.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12653815     DOI: 10.1046/j.1360-0443.2003.00334.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  12 in total

1.  Pharmacologically assisted treatment of opioid-dependent youth.

Authors:  Anna Pecoraro; Marc Fishman; Michelle Ma; Gvantsa Piralishvili; George E Woody
Journal:  Paediatr Drugs       Date:  2013-12       Impact factor: 3.022

2.  Young Adults Have Worse Outcomes Than Older Adults: Secondary Analysis of a Medication Trial for Opioid Use Disorder.

Authors:  Marc Fishman; Kevin Wenzel; Jennifer Scodes; Martina Pavlicova; Joshua D Lee; John Rotrosen; Edward Nunes
Journal:  J Adolesc Health       Date:  2020-08-29       Impact factor: 5.012

Review 3.  Buprenorphine Treatment for Adolescents and Young Adults With Opioid Use Disorders: A Narrative Review.

Authors:  Jacob T Borodovsky; Sharon Levy; Marc Fishman; Lisa A Marsch
Journal:  J Addict Med       Date:  2018 May/Jun       Impact factor: 3.702

Review 4.  The association between outpatient buprenorphine detoxification duration and clinical treatment outcomes: a review.

Authors:  Kelly E Dunn; Stacey C Sigmon; Eric C Strain; Sarah H Heil; Stephen T Higgins
Journal:  Drug Alcohol Depend       Date:  2011-07-08       Impact factor: 4.492

5.  The multi-site prescription opioid addiction treatment study: 18-month outcomes.

Authors:  Jennifer Sharpe Potter; Jessica A Dreifuss; Elise N Marino; Scott E Provost; Dorian R Dodd; Lindsay S Rice; Garrett M Fitzmaurice; Margaret L Griffin; Roger D Weiss
Journal:  J Subst Abuse Treat       Date:  2014-08-02

Review 6.  In the shadow of academic medical centers: a systematic review of urban health research in Baltimore City.

Authors:  Nadra C Tyus; M Christopher Gibbons; Karen A Robinson; Claire Twose; Bernard Guyer
Journal:  J Community Health       Date:  2010-08

7.  A multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): rationale, design, and methodology.

Authors:  Roger D Weiss; Jennifer Sharpe Potter; Scott E Provost; Zhen Huang; Petra Jacobs; Albert Hasson; Robert Lindblad; Hilary Smith Connery; Kristi Prather; Walter Ling
Journal:  Contemp Clin Trials       Date:  2010-01-29       Impact factor: 2.226

Review 8.  Buprenorphine for managing opioid withdrawal.

Authors:  Linda Gowing; Robert Ali; Jason M White; Dalitso Mbewe
Journal:  Cochrane Database Syst Rev       Date:  2017-02-21

9.  Memantine improves buprenorphine/naloxone treatment for opioid dependent young adults.

Authors:  Gerardo Gonzalez; Gregory DiGirolamo; Mauricio Romero-Gonzalez; David Smelson; Douglas Ziedonis; Monika Kolodziej
Journal:  Drug Alcohol Depend       Date:  2015-09-30       Impact factor: 4.492

10.  Brief vs. extended buprenorphine detoxification in a community treatment program: engagement and short-term outcomes.

Authors:  Elizabeth C Katz; Robert P Schwartz; Stuart King; David A Highfield; Kevin E O'Grady; Timothy Billings; Devang Gandhi; Eric Weintraub; David Glovinsky; Wardell Barksdale; Barry S Brown
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.